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SPECT/CT Single-Photon Emission Computed Tomography / CT
SPECT Single-Photon Emission Computed Tomography
PET Positron-Emission Tomography
CT Computed Tomograpy
NET Neuroendocrine tumor
PC Prostate Cancer
PSMA Prostate Specific Membrane Antigen
TAC Time Activity Curve
TIA Time Integrated Activity
VOI Volume Of Interest
PF Particle Filter
SNR Signal to Noise Ratio
KL Kullback-Leibler divergence
CgA Chromogranin A level
PSA Prostate Specific Antigen
SEM State Evolution Model
OM Observation Model
SIR Sampling Importance Resampling
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Chapter 1
Introduction
Therapy with Lu-177-labelled somatostatin analogues and PSMA inhibitors are
established tools in the management of patients with inoperable and metastasised
neuroendocrine tumours (NET) and prostate cancer (PCa) [27, 8]. Dosimetry
could provide information for assessing the patient-individual dose-burden due to
radiotherapy with Lu-177-DOTATOC and Lu-177-PSMA as radiopharmaceutical
[32]. Most commonly, the pharmaceutical is delivered over several (3-6) therapy
cycles, where at the first cycle a dosimetry is performed. For this, several SPECT
images can be collected at multiple time points. The resulting organ-wise time-
activity-curve (TAC) is then integrated to estimate the cumulated activity, which,
together with the so called S-value determines the energy dose, according to the
Medical Internal Radiation Dose (MIRD) scheme. From this, the dose limiting
organ is identified (often being kidneys), and the total amount of injected activity
which can be applied over multiple subsequent radiotherapy cycles is determined.
Commonly, the dose assessment is limited to mean-organ doses, since per-voxel
3-D dose-distributions are often regarded as too noisy for estimating absorbed
energy doses. Nevertheless, some studies from literature regarding this topic are
available.
1.1 Literature on Lu-177 Dosimetry
In the following, a brief overview of the literature regarding dosimetry based on
organ- or voxel-wise time-activity curves is provided:
Patient-specific dosimetry for I-131 tyroid tumor therapy is reported in [25].
Such personalized dosimetry better accounts for radionuclide distribution and pa-
tient anatomy. However, its accuracy depends on the quality of the cumulated ac-
tivity which enters the dosimetric calculations and which is derived from SPECT
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or PET imaging studies. Three to four image acquisitions were performed in 15
patients with metastatic tyroid carcinomas. A voxel-wise integration over time of
the PET images provided a 3D spatial distribution of accumulated activity, and
absorbed dose maps were obtained employing the software package 3D Internal
Dosimetry. The study indicated a high inter-tumor and inter-patient variability of
absorbed dose distribution underlining the need for a patient-specific dosimetry.
A similar study is reported in [30], where the dosimetry in I-131 internal emit-
ter therapy is discussed for follicular lymphoma patients being treated with I-131-
tositumomab. The study employs voxel-wise integration of time-activity-curves
derived from SPECT/CT images at multiple time points, which were subsequently
registered at multiple time points on a dual-modality scanner. Maps of integrated
TACs have been used together with CT images to determine absorbed energy dose
spatial distributions by Monte Carlo (MC) simulations. Results are compared to
state-of-the-art dosimetric calculations.
A PRRT with Lu-177-labeled somatostatin analogues has been reported al-
ready by [29]. In their study, the authors compared the dosimetric parameter
uptake, half-life (kinetics), and mean absorbed organ and tumor doses of Lu-177-
DOTA-NOC and Lu-177-DOTA-TATE in 69 patients suffering from a NET with
high somatostatin receptor expression. Absorbed doses were assessed using the
MIRD scheme. DOTA-TATE showed a higher uptake in tumor lesions as well as
a higher mean absorbed dose. However, the high inter-patient variability deemed
an individualized dosimetry obligatory.
Individualized dosimetry in patients undergoing therapy with Lu-177-DOTA-
D-Phe-Ryr-octreotate was studied in [21]. SPECT data were analyzed considering
whole organ volumes of interest (VOIs) to obtain the amount of radioactivity in the
organ. In addition, small VOIs were employed to estimate the radioactivity con-
centration in the respective tissues. With a cohort of 24 patients SPECT images
were acquired at 1h, 24h, 96h, and 168h after infusion of the radio-pharmaceutical
and absorbed doses were calculated in non-tumor affected organs like kidney,
spleen and liver. Authors concluded that SPECT dosimetry based on small VOIs
has been more reliable and delivered more accurate results than conventional pla-
nar dosimetry or dosimetry based on whole organ VOIs.
In a later study of Lu-177-labeled peptides for NET therapy, [12] observed
that side effects are few and remain mild, if kidney-protective agents were used,
thus increasing the progression-free survival to more than 40 months. Apart from
kidneys, bone marrow is another organ at risk in radionuclide therapy.
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In [22] an individualized dosimetry protocol for the bone marrow was devel-
oped. Furthermore, patients, undergoing fractionated therapy with 7.4 GBq/cycle,
were identified who first reached an accumulated dose of either 2 Gy to the bone
marrow or 23 Gy to the kidneys. Planar whole-body and SPECT/CT images over
the abdomen were acquired at 24h, 96h, and 168h after administering Lu-177-
octreotate. In addition, blood samples were collected six times during the first
24h, with additional blood samples taken at 96h and 168h from several patients.
Also urine samples were taken from several patients during the first 24h. The
absorbed radiation dose was computed from blood and urine activity curves as
well as an organ-based analysis of whole body images. The absorbed dose to the
kidney was calculated from the pharmacokinetic data obtained from SPECT/CT.
The study revealed that the kidney was the dose limiting organ in 197 out of 200
patients. The number of cycles until the limiting dose was reached showed a high
variability (2−10 cycles), thus suggesting the need for an individualized radiation
treatment.
Another recent study by [10] proposed an automatized voxel-wise dosime-
try tool for radiotherapy based on multiple SPECT/CT images. The latter were
acquired at 4, 24, 72 hours after Lu-177-DOTATATE PRRT for 17 patients suf-
fering from advanced NETs. Deformable image registration and in-house de-
veloped algorithms for pharmacokinetic uptake interpolation at voxel level were
employed. Absorbed energy dose was computed from cumulated activity based
on MC-determined voxel S-values and compared to results obtained using a con-
ventional MIRD protocol (OLINDA).
Dosimetry of organs and tumors is often avoided because of the additional
burden for patients. Therefore, in [7] an approximation has been advocated which
allows the calculation of absorbed energy doses from a single measurement of
the abdominal radioactivity distribution. In the study, the activity kinetics were
assessed in 29 patients suffering from NETs or meningioma after administering
Lu-177-DOTATATE or -DOTATOC. Mono-or bi-exponential decay curves were
fit to SPECT/CT imaging data from kidneys, livers, spleens and NET lesions. The
time-integrated activity was compared to an approximation given by the product
of three factors: the time t of a single measurement, the expected reading at time
t and the factor 2/ ln 2. Tissue-specific deviations of the approximation from the
time-integrated activity were computed for several time points ranging from t =
24h to t = 144h. Results were inconclusive in that best accordance was achieved
for t = 96h, while a reduced accuracy resulted for shorter and longer time spans.
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Chapter 2
Dataset
2.1 Patient collectiv
Table 2.1: Patient data concerning the DOTATOC radiotherapy. Here m denotes
the weight of each person, A0 the initially injected radioactivity, g the grading
of the NET, CgA1 denotes the CgA before therapy and CgA2 after therapy, ∆t
the time betweent the CgA values, n the number of therapy cycles and the sex is
coded in 1 for female and 0 for male.
Age sex g m A0 CgA1 CgA2 ∆t n
[y] (kg) (MBq) (µg/l) (µg/l) (m)
45 1 3 64 6077 494 1026 5 4
66 0 3 79 6375 1121 706 4 4
54 0 1 77 7054 661 1956 4 2
67 1 2 70 6821 1352 1473 6 3
78 0 2 88 5773 34 31 4 3
54 0 2 56 7023 54 77 4 3
67 0 2 75 5809 597 1748 2 2
54 0 2 71 6644 1319 682 4 4
77 1 2 49 6378 224 246 1 1
52 0 3 78 6233 46 83 5 2
52 0 3 103 7265 76 47 4 3
71 0 2 118 6757 51 51 3 2
49 0 3 80 6328 139 214 2 2
66.5 2.3 77.5 6503 589.8 768.1 3.9 2.8
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Table 2.2: Patient data concerning the PSMA radiotherapy. Here m denotes the
weight of each person,A0 the initially injected radioactivity,Gleason the Gleason
Score of the PC, PSA1 denotes the PSA level before therapy and PSA2 after
therapy, ∆t the time betweent the PSA values and n the number of therapy cycles.
Age Gleason m A0 PSA1 PSA2 ∆t n
[y] (kg) (MBq) (ng/ml) (ng/ml) (m)
80 9 88 6699 1277 594 2 1
67 8 104 6997 96 120 6 2
75 9 74 6314 22 5 2 1
55 6 113 5931 122 523 2 1
61 9 85 6899 32 74 5 2
66 9 97 7139 92 199 2 1
63 9 94 7103 484 289 2 1
65 9 80 7030 58 0.1 3 2
66 9 86 6545 469 445 1 1
78 9 106 6768 93 86 3 2
79 9 75 6915 138 25 2 1
62 8 68 6824 2251 1946 2 1
55 9 94 7006 148 53 2 2
65.7 8.4 90 6782 406.3 336.0 2.6 1.4
This study comprises 26 patients suffering from NETs (13) or Prostate Cancer
(PC) (13) and which underwent a 177Lu-DOTATOC or 177Lu-Prostate Specific
Membrane Antigen (PSMA) therapy. The patient cohort consists of 23 male and
3 female patients with an average age of 63.8 ± 10 years at time of therapy. The
on average injected activity was A0 = 6643± 421 MBq.
The information about the patients suffering on NET is collected in table 2.1
and for the patients with prostate cancer in 2.2.
2.2 Image Acquisition
2.2.1 Single-Photon Emission Computed Tomography (SPECT)
Data was acquired on a Single-Photon Emission Computed Tomography / CT
(SPECT/CT) system (Siemens Symbia T2) at time points 4h, 24h, 48h, and 72h
after administering the radiopharmaceutical. The acquisition of the 24 h p.i. im-
age was carried out as part of a hybrid SPECT/CT acquisition, After manual co-
registration, the Computed Tomograpy (CT) part was used for attenuation correc-
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tion of the subsequent SPECT. Acquisition was done based on an inhouse stan-
dard quantitative 177Lu - protocol, which is described in detail in [20]. Therefore,
it is herein only briefly outlined:
• SPECT using medium energy collimators, 3◦ angular sampling, 15 min total
dwell time
• Iterative ordered-subset conjugate-gradient reconstruction of the 208 keV
photopeak data with 24 iterations, 1 subset, matrix 256x256
• Point-spread-function modelling in reconstruction
• Triple energy window based scatter correction
• CT-based attenuation correction
• No post-reconstruction smoothing
The reconstruction, using the ordered-subset conjugate-gradient algorithm,
was carried out on a Siemens research workstation. The algorithm outputs fully
quantitative reconstructed SPECT images providing activities per voxel measured
in [Bq/ml]. Furthermore the SPECT data is alined with the corresponding CT
data.
2.2.2 CT
Additionally, a low-dose CT was carried out as part of the multi-modal SPECT/CT
acquisition to enable necessary attenuation corrections of the SPECT images. The
CT covered the same field-of-view as the SPECT and was acquired and recon-
structed using the following parameters:
• Slice collimation of 2 x 5 mm, pitch of 1.8, time per rotation of 0.8 s, tube
voltage of 130 kVp, tube current of 30 mAs effective
• Filter-Back-Projection reconstruction with B08s and B41s Kernels, 512x512
matrix, 2.5 mm slice thickness
• B08s image was used for attenuation correction of the SPECT data
• B41s image was used for defining organ and tumor volumes-of-interest
Reconstructed SPECT images were partitioned into voxels of size Vvox =
4.79 mm3 and were cropped to 823 voxels. Thereby large portions of the re-
constructed volume were removed which predominantly contained air.
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2.3 Common Preprocessing
Figure 2.1: CT-image, SPECT-image and hyprid SPECT/CT-image as shown in
ITK-snap. In the right bottom corner the segmentation of the right and left kidney,
the spleen and a liver tumor can be seen.
In figure 2.1 a CT-image, a SPECT-image and a SPECT/CT-image are pre-
sented. For all patients, the kidneys, spleen and tumors were segmented by a
medical expert. The tumors were sorted to bone lesion, lymph nodes, visceral
and primary tumor. The segmentation was done using the software ITK-snap
[31], which was carried out on the original CT datasets. The resulting segmenta-
tion was subsequently down-sampled to match the voxel-size of (4.7mm)3 of the
SPECT image. For each patient, the follwoing information is available:
• SPECT-Image acquired 4h after injection
• SPECT-Image acquired 24h after injection
• SPECT-Image acquired 48h after injection
• SPECT-Image acquired 72h after injection
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• CT-Image acquired 24h after injection
• Organ and tumor segmentation
Exemplarly, for one patient and one slice the eight images are illustrated in
figure 2.2.
Figure 2.2: The four SPECT-images, the CT-image and the corresponding seg-
mentation map illustrated for one slice of one patient.
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Chapter 3
Sequential Monte Carlo Techniques
Non-linear dynamical systems evolve either continuously or via transitions be-
tween discrete states. The latter approximation is only reasonable if the mean
residence time in any state is longer than the transition time. Particle filters repre-
sent discrete state space models which estimate the states X(r, t) of a dynamical
system from noisy and disturbed observations Z(r, t). This is achieved by com-
bining available measured data Z(r, t) with prior knowledge about the underlying
physical phenomena driving the dyanmics and the measurement process. The un-
derlying physics allow to construct a state evolution model while the known mea-
surement process provides information to construct an observation model. With
these ingredients and observations of the system dynamics, estimates of the unob-
servable dynamic state variables can be produced sequentially.
3.1 Background
State evolution models are commonly based on a Markov model, while obser-
vation models need to reflect the specifics of the physical measurement process.
Both, evolution and observation models are most often described in terms of con-
ditional probability density functions. Hence we have (throughout we use the
short hand notation z(tk) ≡ zk, {z(t0), . . . , z(tk)} ≡ z0:k etc.)
xk+1 ∼ p (xk+1|x0:k) ≈ p (xk+1|xk) (3.1)
zk ∼ p (zk|x0:k) ≈ p (zk|xk) (3.2)
where ∼ means “represented through”, xk denotes an unobservable state vector
of the dynamical system and zk a corresponding observation vector of the system
through a measurement at discrete time tk [15]. Note that the conditional proba-
bility densities only depend on the last state of the system. This is in accord with
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the Markov assumption which expresses common intuition that any prediction
of a future state should be based primarily on the recent history of the evolving
system.
Now given the task that we want to predict unobservable states of an evolv-
ing system from sequential noisy observations, Bayesian inference [17] allows to
integrate available information, i. e. observations z0:k and an associated physical
model of the dynamical system, parametrized through dynamic states x0:k. As
new information zk is available, it can be combined with previous information
p(x0:k−1, z0:k−1) via the Bayes Theorem to deduce the underlying system state
xk. Employing the Markov assumption we have
p(xk|z0:k) = p(xk|zk, z0:k−1) ≈ p(zk|xk)p(xk|zk−1)∑
k (p(zk|xk)p(xk|zk−1))
(3.3)
The latter forms the basis for statistical estimates of the posterior density
p(xk|z0:k) of the unobservable state vector xk given the likelihood of the obser-
vation p(zk|xk), some prior knowledge p(xk|zk−1) about the observation process
and the data evidence p(zk).
Note that the term posterior density denotes different densities depending on
the application:
• Filtering: p(xk|z0:k)
• Prediction: p(xk+τ |z0:k)
• Smoothing: p(xk−τ |z0:k)
where τ > 0 denotes the prediction or smoothing lag.
The most widely known Bayesian filter method is the Kalman filter [11],
which, however, relies on linear models with additive Gaussian noise, i. e. it
assumes the distribution p(xk|z0:k) to be a multi-variate Gaussian. Extensions
of the Kalman filter concern sequential Monte Carlo methods [4] which repre-
sent the posterior density in terms of random samples (particles) and associated
weights. Such sequential Monte Carlo methods are variously known as Particle
Filter, bootstrap filter [5], survival of the fittest [13], condensation algorithm [9]
and can be applied to non-linear models with non-Gaussian errors [2]. Thus, given
any dynamical state representation f(xk), one can estimate the related expected
value via
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E(f(xk)) =
∫
f(xk)p(xk|z0:k)dxk
=
∫
f(xk)p(zk|xk)p(xk|zk−1)dxk∫
p(zk|xk)p(xk|zk−1)dxk
≈
L∑
l=1
w
(l)
k f(x
(l)
k ) (3.4)
Here x(l)k denotes a set of samples, called particles, drawn from the posterior dis-
tribution p(xk|zk−1). The sampling weights are given by
w
(l)
k =
p
(
zk|x(l)k
)
∑L
l′=1 p
(
zk|x(l′)k
) (3.5)
where the same samples are used in the numerator and the denominator. Hence
a particle filter approximates the posterior distribution p(xk|z0:k) by a set of par-
ticles x(l)k , sampled from p(xk|zk−1), and their weights {w(l)k }. The latter are
normalized to 0 ≤ w(l)k ≤ 1 and obey the closure relation
∑
l w
(l)
k = 1.
In practice one is concerned with a sequential sampling scheme, which works
as follows:
• Suppose, a set of samples {x(l)k } and related weightsw(l)k have been obtained
at time tk. These samples and weights represent the posterior distribution
p(xk|zk) at time step tk.
• Suppose, an observation zk+1 has been made subsequently
How can one estimate corresponding samples x(l)k+1 and weights w
(l)
k+1?
• First, new samples are drawn from the distribution
p(xk+1|z0:k) =
∫
p(xk+1|xk, z0:k)p(xk|z0:k)dxk
=
∫
p(xk+1|xk)p(xk|z0:k)dxk
=
∫
p(xk+1|xk)p(xk|zk, z0:k−1)dxk
=
∫
p(xk+1|xk)p(zk|xk)p(xk|zk−1)dxk∫
p(zk|xk)p(xk|zk−1)dxk
=
L∑
l=1
w
(l)
k p
(
xk+1|x(l)k
)
(3.6)
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where the conditional independence property has been used
p(xk+1|xk, z0:k) = p(xk+1|xk) (3.7)
p(zk|xk, z0:k−1) = p(zk|xk) (3.8)
The above distribution is a mixture distribution. Hence, samples x(l)k can be
drawn by choosing a mixture component l with probabilityw(l)k and drawing
a sample from the corresponding mixture component of the distribution.
• Second, for each sample the new observation zk+1 is used to estimate the
related weights
w
(l)
k ∝ p(zk+1|x(l)k+1) (3.9)
Thus using a probabilistic description and the Markov assumption, one is con-
cerned with the following densities:
• The likelihood of the state p(xk|zk−1)
• The Markov transition model p(xk+1|xk)→ state evolution model
• The sensor model p(zk|xk)→ observation model
3.2 State Estimation
While theoretical derivations are based on the general Markov model, algorithms
are based on evolution and observation models as detailed next.
3.2.1 The model equations
Let the dynamic state of a system be described by a state vector x(t) ∈ RN
whose components represent the dynamical variables of the system. The dynamic
evolution of the system, called the state evolution model f(...), is described by the
following equation for the state vector
x(tk) ≡ xk = f
(
xk−1, (x)
)
(3.10)
where k = 1, 2, ....... denotes discrete time instances tk and (x) ∈ RL denotes the
state noise.
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If measurements are available at tk, they are collected in the observation vector
z, and its relation to the state vector is given by the observation model h(...)
z(tk) ≡ zk = h
(
xk, 
(m)
)
(3.11)
where (m) ∈ RM denotes the measurement noise. The various noise distributions
p((x)) and p((m)) are assumed to be known. In some applications, also additional
known control variables uk enter the problem, but are omitted here.
The state estimation problem aims at obtaining information about the state
vector xk based on the state evolution model f(...) and based on the measurements
z1:k, given by the observation model h(...).
3.2.2 The simplifying assumptions
The state evolution and observation models rely on the following simplifying as-
sumptions:
• The sequence of state vectors xk forms a Markov process [3] and does not
depend on the sequence of observations
p(xk|x0:k−1, z1:k−1) = p(xk|xk−1) (3.12)
• The observations zk form a Markov process with respect to the history of
the state vector xk, i. e.
p(zk|x0,x1,x2, . . . ,xk−1) = p(zk|xk) (3.13)
• The probability of an observation only depends on the current state
p(zk|x0:k, z1:k−1) = p(zk|xk) (3.14)
• For i 6= j the noise vectors (x)i and (x)j , as well as (m)i and (m)j , are
mutually independent
• The noise vectors (x)i and (m)j are mutually independent for all i, j =
1, 2, ....
• All noise vectors are also mutually independent of the initial state x0
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3.2.3 The problems to be solved
Several problems can be tackled with this approach
• The prediction problem determines p(xk|z1:k−1), i. e. it predicts the state of
the system at time tk based on observations made at times t1, . . . , tk−1
• The filtering problem determines p(xk|z1:k), i. e. it filters out from the ob-
servations made up to time point tk the state of the system at time tk.
• The fixed lag smoothing problem determines p(xk|z1:k+τ ), i. e. it deter-
mines the state of the system at time tk given observations over a time span
t1, . . . , tk+τ , where τ ≥ 1 denotes the fixed time lag.
• The whole domain smoothing problem determines p(xk|z1:K), where z1:K =
zi, i = 1, . . . , K denotes the complete observation sequence.
In this study, only the filtering problem is of interest here. By assuming that
p(x0|z0) = p(x0) is available, the posterior probability density p(xk|z1:k) is then
obtained with Bayesian filters in two steps: prediction and update.
3.3 Bayesian Filters
The Bayesian solution to compute the posterior distribution, p(xk|z1:k), of the
state vector x(tk), given past observations z1:k, is given by the general Bayesian
update recursion
measurement update : p (xk|z1:k) = p(zk|xk)p(xk|z1:k−1)
p(zk|z1:k−1) (3.15)
normalization : p(zk|z1:k−1) =
∫
RN
p(zk|xk)p(xk|z1:k−1)dxk (3.16)
time update : p(xk+1|z1:k) =
∫
RN
p(xk+1|xk)p(xk|z1:k)dxk(3.17)
The posterior distribution is the primary output from a nonlinear filter, from
which standard measures as the minimum mean square estimate xˆmmsk|k and its
covariance C(x),mmsk|k can be extracted:
xˆmmsk|k =
∫
xkp(xk|z1:k)dxk (3.18)
C
(x),mms
k|k =
∫
(xk − xˆmmsk ) (xk − xˆmmsk )T p(xk|z1:k)dxk (3.19)
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For a linear Gaussian model, the Kalman filter recursion relations provide a
solution to this Bayesian filtering problem. But for non-linear or non-Gaussian
models no finite-dimensional representations of the posterior density exist, and
numerical approximations are needed.
3.4 Particle Filter
If linear Gaussian evolution - observation models are inadequate, the use of the
Kalman filter does not result in optimal solutions. In such cases the posterior
density of underlying states xk, given the sequence of observations z0:k is not
analytic, implying that the distribution p(xk|z0:k) cannot be expressed in a simple
form. The application of Monte Carlo techniques then appears as the most general
and robust approach to analyze non-linear system dynamics and/or non-Gaussian
state distributions. This is the case despite the availability of the so-called ex-
tended or unscented Kalman filter, which generally involves a linearization of the
problem.
The particle filter (PF) is also known under various names as there are:
• the bootstrap filter,
• the condensation algorithm,
• interacting particle approximations,
• survival of the fittest.
The particle filter approximates the posterior distribution of unobservable states,
p(xk|z0:k), with a discrete density which will be evaluated at a dynamic stochastic
grid in this work.
3.4.1 Sampling on a dynamic stochastic grid
The Particle Filter (PF) is based on a direct application of the Bayesian recursion
relations and approximates the posterior distribution, p(xk|z0:k), with a discrete
density sampled on a dynamic stochastic grid. This kind of sampling has some
noteworthy properties:
• A dynamic stochastic grid xik changes over time and represents a very effi-
cient representation of the state space.
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• The PF generates and evaluates a set {xi1:k}Ni=1 of N different trajecto-
ries rather than current states xik only. This affects the time update of the
Bayesian recursion relations as follows:
p
(
xi1:k+1|z1:k
)
= p
(
xi1:k|z1:k
)
p
(
xik+1|xi1:k, z1:k
)
= wik|kp
(
xik+1|xik
)
(3.20)
• The new grid is obtained by sampling from
p (xk+1|z1:k) =
N∑
i=1
p
(
xi1:k+1|z1:k
)
=
N∑
i=1
wik|kp
(
xik+1|xik
)
(3.21)
Employing importance sampling amounts to introducing an auxiliary proposal
density q (xk+1|xk, zk+1), from which it is easy to sample. The advantage of us-
ing an auxiliary proposal distribution can be seen, if one re-writes the Bayesian
recursion as follows:
p (xk+1|z1:k) =
∫
RN
p (xk+1|xk) p (xk|z1:k) dxk (3.22)
=
∫
RN
q (xk+1|xk, zk+1) p (xk+1|xk)
q (xk+1|xk, zk+1)p (xk|z1:k) dxk
Now for each particle a random sample from this auxiliary proposal distribu-
tion xik+1 ∼ q (xk+1|xik, zk+1) is drawn, and the posterior probability is adjusted
for each particle with the importance weight
p (x1:k+1|z1:k) =
N∑
i=1
p
(
xik+1|xik
)
q
(
xik+1|xik, zk+1
)wik|kδ (x1:k+1 − xi1:k+1)
= wik+1|kδ
(
x1:k+1 − xi1:k+1
)
(3.23)
Note that the proposal distribution q
(
xik+1|xik, zk+1
)
depends on the last state
in the particle trajectory xik as well as the next measurement zk+1. The sim-
plest choice of proposal distribution is to use the dynamic model itself, i. e.
q
(
xik+1|xik, zk+1
)
= p
(
xik+1|xik
)
, leading to wik+1|k = w
i
k|k.
Thus, the Particle Filter is a sequential Monte Carlo technique for the solution
of the state estimation problem. It is a sampling method which approximates the
posterior distribution by making use of its temporal structure. Again, the key
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idea is to represent the required posterior density function by a set of random
samples (particles) with associated weights yielding a particle representation of
the posterior density according to
p(xk|z0:k) ≈
N∑
i=1
wik−1δ
(
xk − xik−1
)
(3.24)
where wik represents the weight of particle x
i
k. Estimates are then computed based
on these samples and weights. As the number of samples becomes very large,
this Monte Carlo characterization becomes an equivalent representation of the
posterior probability function, and the solution approaches the optimal Bayesian
estimate.
Note that for the posterior density a recursive representation exists according
to
p (xk|z0:k) = α · p (zk|xk)
∫
dxk−1p (xk−1|z0:k−1) p (xk|xk−1) (3.25)
With a particle representation, this recursive relation simplifies to
p (xk|z0:k) ≈ α · p (zk|xk)
N∑
i=1
wik−1p
(
xk|xik−1
)
(3.26)
How do we create a proper set of particles for representing the posterior distri-
bution p (xk|z0:k)? The answer is importance sampling which will be explained
next.
3.4.2 Sequential importance sampling
The technique of importance sampling is a method for generating fair samples of
a distribution p(x(t)). Suppose p(x(t)) is a density from which it is difficult to
draw samples, but it is easy to evaluate p(xi(t)) for some particular instances xi,
i. e. on a grid. Then, an approximation to p(x) can be given by:
p(x) ≈
N∑
i=1
wiδ
(
x− xi) (3.27)
wi =
p(x)
q (xi)
(3.28)
where q(xi) denotes any auxiliary proposal distribution, also called importance
density. In particular, a uniform sampling of the state space could be used but
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would lead to sample depletion, or sample degeneracy, or sample impoverish-
ment. A more direct auxiliary proposal distribution would be an approximation
to the posterior density p (xk|z1:k). This is achieved by re-sampling, which intro-
duces the required information feedback from the observations, so trajectories that
perform well, will survive the re-sampling.
3.4.3 A generic Particle Filter algorithm
• Choose
– a proposal distribution q (xk+1|x1:k, zk+1),
– a re-sampling strategy and
– the number of particles N .
• Initialization: Generate xi1 ∼ px0 , i = 1, . . . , N and set wi1|0 = 1N .
• Iteration: for k = 1, 2, ...... do
– Measurement update: For i = 1, 2, . . . , N compute
wik|k =
wik|k−1p (zk|xik)∑N
i=1w
i
k|k−1p (zk|xik)
(3.29)
– Estimation: The filtering posterior density is approximated by
pˆ (x1:k|z1:k) =
N∑
i=1
wik|kδ
(
x1:k − xi1:k
)
(3.30)
and the mean is approximated by
〈x〉 ≈
N∑
i=1
wik|kx
i
1:k (3.31)
– Re-sampling: Optionally at each time, take N samples with replace-
ment from the set {xi1:k}Ni=1 where the probability to take sample i is
wik|k = 1/N
– Time update: Generate predictions according to the chosen proposal
density
xik+1 ∼ q
(
xk+1|xik, zk+1
)
(3.32)
and compensate for the importance weight
wik+1|k = w
i
k|k
p
(
xik+1|xik
)
q
(
xik+1|xik, zk+1
) (3.33)
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Note that the algorithm exhibits the fundamental structure of the Bayesian
recursion relations as detailed above. Most common forms of PF algorithms com-
bine the weight updates into one equation according to
wik|k ∝ wik−1|k−1
p (zk|xik) p
(
xik|xik−1
)
q
(
xk|xik−1, zk
) (3.34)
The PF algorithm outputs an approximation of the trajectory posterior density
p (x1:k|z1:k). For a filtering problem, the simplest solution would be just to extract
the last state xik from the trajectory x
i
k and use the particle approximation
pˆ (xk|z1:k) =
N∑
i=1
wik|kδ
(
xk − xik
)
(3.35)
However, this is incorrect as in general all paths xj1:k−1 can lead to the state x
i
k. The
correct solution, taking all paths leading to xik into account, leads to an importance
weight
wik+1|k =
N∑
j=1
wjk|k
p
(
xik+1|xjk
)
q
(
xik+1|xik, zk+1
) (3.36)
which replaces the time update of the normalized weights given in the generic PF
algorithm above. This solution is called the marginal Particle Filter (mPF) which
has many applications in system identification and robotics. Unfortunately, the
complexity is now of order O(N2).
Prediction to get p (x1:k+m|z1:k) can be implemented by repeating the time
update in the generic PF algorithm m times.
3.4.4 Importance re-sampling
The basic particle filter suffers from sample depletion where all but a few particles
will have negligible weights. Re-sampling solves this problem, but inevitably
destroys information and thus increases uncertainty by the random sampling. In
this work the bootstrap PF, also called Sampling Importance Resampling (SIR),
is employed which applies re-sampling each time. To avoid sample depletion,
an auxiliary importance density needs to be selected appropriately as the prior
density p
(
xk|xik−1
)
.
3.4.5 The SIR algorithm
The SIR algorithm uses re-sampling at every iteration. It can be summarized in
the following steps, as applied to the system evolution from tk−1 to tk:
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Step 1 – For i = 1, . . . , N draw new particles xik from the importance density
by employing the transition model
q(xk) =
N∑
i=1
wik−1p
(
xk|xik−1
)
(3.37)
To do so, choose a random number r uniformly from [0, 1] and choose
particle i = r, then sample from the prior density p
(
xk|xik−1
)
.
– Use the corresponding likelihood to calculate corresponding weights
wik = p
(
zk|xik
)
(3.38)
The samples xik, employed above, are fair samples from p (xk|z0:k−1)
and re-weighting them accounts for the evidence of the observations
zk.
Step 2 Calculate the total weight Wk =
∑N
i=1w
i
k.
Normalize the particle weights wik = W
−1
k w
i
k ∀i = 1, ...., N
Step 3 Re-sample the particles by doing
– Compute the cumulative sum of weights W ik = W ik−1 + wik;∀i =
1, . . . , N, W 0 = 0
– Let i = 1 and draw a starting point u1 from a uniform distribution
U [0, N−1]
– For j = 1, . . . , N do the following
∗ move along the cumulative sum of weights by setting uj = u1 +
N−1(j − 1)
∗ while uj > W i set i = i+ 1
∗ assign samples xjk = xik
∗ assign weights wjk = N−1
The resampling procedure just described avoids to have many degenerate par-
ticles with vanishing weights but it also leads to a loss of diversity in the sense that
the resulting samples may contain many redundant particles. This phenomenon
is called sample impoverishment and is often observed in case of small process
noise. In this situation, all particles collapse to a single particle within few in-
stants tk.
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3.4.6 Effective number of samples
An indicator of the degree of depletion is the effective number of samples, defined
in terms of the coefficient of variation σx as
Neff =
N
1 + σ2x(w
i
k|k)
(3.39)
The effective number of samples is thus at its maximum Neff = N when all
weights are equal wik|k =
1
N
, and the lowest value it can attain is Neff = 1,
which occurs when wik|k = 1 with probability 1/N and w
i
k|k = 0 with probability
(N − 1)/N .
In practical applications this number could be approximated by
Nˆeff =
1∑N
i=1
(
wik|k
)2 (3.40)
when we have 1 ≤ Nˆeff ≤ N . Again the upper bound Neff = N is attained
when all particles have the same weight, and the lower bound Neff = 1 when all
the probability mass is devoted to a single particle. The resampling condition in
the PF can now be defined as Neff < Nth, and the threshold can for instance be
chosen as Nth = 2N3 .
3.4.7 Choice of proposal/importance distribution
The choice of proposal distribution clearly influences the depletion problem. The
most general proposal distribution has the form q (x1:k|z1:k). This means that the
whole trajectory needs be sampled at each iteration, which in real-time applica-
tions is not realistic. But the general proposal can be factorized as
q (x1:k|z1:k) = q (xk|x1:k−1, z1:k) q (x1:k−1|z1:k) (3.41)
The most common approximation in applications is to reduce the path x1:k−1
and only sample the new state xk, so the proposal distribution q (x1:k|z1:k) is re-
placed by q (xk|x1:k−1, z1:k), which, due to the Markov assumption, can be written
as
q (xk|x1:k−1, z1:k) ≈ q (xk|xk−1, zk) . (3.42)
The approximate proposal density predicts good values of the current state xk
only, not of the whole trajectory x1:k. For further insight, one needs to discuss
the dependence of this proposal distribution on the Signal to Noise Ratio (SNR).
22
Here, the SNR is defined as the ratio of the maximal value of the likelihood and
prior, respectively,
SNR ∝ maxxkp(zk|xk)
p(xk|xk−1) (3.43)
Note that for a linear Gaussian model this yields
SNR ∝
√
det(Cx)
det(Cm)
(3.44)
Thus, the SNR is high if the measurement noise is small compared to the signal
noise. Given this measure, one could consider different sampling strategies, but
here only the one used in this work is explained.
Likelihood sampling: For medium or high SNR, samples are drawn from the
likelihood p (zk|xk).
The proposal distribution q
(
xk|xik−1, zk
)
can be factorized as follows
q
(
xk|xik−1, zk
) ≈ p (xk|xik−1, zk) = p (xk|xik−1) p (zk|xik−1,xk)p (zk|xik−1)
= p
(
xk|xik−1
) p (zk|xk)
p
(
zk|xik−1
) (3.45)
Now consider the case that the likelihood p (zk|xk) is much more peaky than the
prior p(xk|xk−1) and if it is integrable in state space, xk, then one can set
d2(xn,xm)p
(
xk|xik−1, zk
) ∝ p (zk|xk) (3.46)
Thus, a suitable proposal distribution for the high SNR case is based on a scaled
likelihood function
q
(
xk|xik−1, zk
) ∝ p (zk|xk) (3.47)
This choice then yields the following weight update
wik|k = w
i
k−1|k−1p
(
xik|xik−1
)
(3.48)
Sampling from the likelihood requires that the likelihood function p (zk|xk) is
integrable with respect to xk. This is not the case when N > L, i. e. the number
of unobservable states is larger than the number of observations (measurements).
The interpretation in this case is that for each value of zk, there is an infinite-
dimensional manifold of possible xk to sample from, each one equally likely.
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3.5 Resampling Schemes
The method of sampling from the likelihood has the drawback that it becomes
unstable as k increases. There is a discrepancy between the weights, therefore
the algorithm can be stabilized by performing a re-sampling sufficiently often.
The weighted approximate density is modified by each re-sampling step. This is
done by eliminating particles with low weights and multiplying particles with an
important weight. The filtering posterior density then becomes:
pˆ (x0:k, z1:k) =
N∑
i=1
ni
N
δ(x0:k − xi0:k) (3.49)
where ni is the number of copies of particle xi0:k. In the following, the three main
re-sampling schemes will be described.
3.5.1 Multinomial Resampling
The multinomial resampling scheme generates N ordered uniform random num-
bers on the interval (0, 1]. The new particle set is selected according to the multi-
nomial distribution [1].
uk = uk+1u˜
1
k
k , with u˜k ∼ U [0, 1)
uN = u˜
1
N
N
xk = x(F
−1(uk))
= xi with i so that uk ∈
[ i−1∑
s=1
ωs,
i∑
s=1
ωs
)
,
where the generalized inverse of the cumulative probability distribution is F−1.
The weights are normalized.
3.5.2 Systematic resampling
With systematic re-sampling, the particle set is selected according to the multino-
mial distribution of N generated ordered numbers uk.
uk =
(k − 1) + u˜
N
, with u˜ ∼ U [0, 1) (3.50)
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3.5.3 Residual resampling
With residual re-sampling, the variance can be decreased. We define:
N i = bnωic+ N¯ i, for i = 1, . . . ,m,
where the N¯1, ..., N¯n are multinomially distributed, and bcmeans the integer part.
The multinomial distribution M(n−R; ω¯1, ..., ω¯n) has the following arguments:
R =
m∑
i=1
bnωic
ω¯i =
nωi − bnωic
n−R , i = 1, ...,m
The multinomial counts N¯1, ..., N¯n are generated in the same way as in the multi-
nomial re-sampling described above.
25
Chapter 4
Time-Integrated Activity Map (TIA)
In this chapter the four SPECT-images as shown in figure 2.2 will be integrated
voxelwise to obtain the number of decays per voxel. The activity values will be
denoised by the particle filter. After the denoising, a mono-exponential function
is fit to the data and integrated over time.
4.1 Particle Filter Method
For dosimetry it is more important to have a patient specific model than an on-
line tracking method. Therefore all SPECT images were used to estimate a state
evolution model. First of all, Volume Of Interest (VOI)s were segmented in a CT
image by a medical expert. To this contour a safety margin of 2 voxels was added
to account for partial volume effects as well as deviations from the registration or
inter-organ movements. By summing up the activity values of all voxels enclosed
by the contour, an organ-specific total activity was obtained for each time point.
An additional time point was added at tk = 600 h, at which the specific activity
was set to 0 Bq/ml deliberately. The time-dependent activity (see figure 4.2)
was expressed by a parametrized analytic function which was fit to the observed
time-dependent activities according to
ln
(
a(t)
a(0)
)
= −
(
ln(2)
T1/2
· t
)
= − t
τeff
(4.1)
Note that the effective lifetime
τeff =
(
1
τphys
+
1
τbiol
)−1
=
T1/2
ln 2
(4.2)
is composed of the physical lifetime of the radionuclide and its biological
lifetime due to the metabolic turnover of the radio-pharmaceutical. While the bi-
ological half-life of the isotope should be identical across an organ, the amplitude
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Figure 4.1: Time activity curve for one kidney: f(0) = 1%IA, T1/2 = 77.9h.
a(0) of the Time Activity Curve (TAC) is different for every voxel. Note that a(0)
is different from the initially injected activity A0 and generally unkown.
4.1.1 State evolution model (SEM)
For each voxel of the kidney an own State Evolution Model (SEM) is computed.
At the beginning, the four activity values of the same voxel plus an additional
value of a(tk) = 0Bq/ml at tk = 600 h are approximated by a mono-exponential
decay. Hereby, the half-life is assumed to be equal to the previously computed
half-life of the whole kidney. From this fit, the amplitude 〈a(0)〉 of the state
evolution model can be obtained. Moreover, the inevitable noise on the data is
modeled as Gaussian white noise with an amplitude corresponding to 0.1〈a(0)〉.
4.1.2 Observation model (OM)
The Observation Model (OM) h represents the distribution of acquisition times of
the SPECT image and is modeled by a Normal distribution around the estimated
particle.
4.1.3 Similarity measure
The aim of the voxelwise integration of the activity is to obtain the number of
nuclear disintegrations NLun for each voxel n ∈ S according to:
NLun =
∫ tK
0
an(t
′)dt′ ≈
K∑
k=1
an(tk) ·∆t (4.3)
where K = 5 in this study. The activity distribution is assumed to be identical for
each voxel, hence it can be estimated for each organ at every time point. This fact
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can be explored to find a good parameter configuration. As similarity measure the
Kullback-Leibler divergence (KL) was used. An averaged histogram of the k = 4
time points was calculated, for which the histograms were centered. A histogram
of the voxel activities h(〈an〉) was calculated, where 〈a〉n = (1/K)
∑
k an(tk)
denotes the activity of voxel n averaged over the four time points. The similarity
between different histograms has been computed employing the KL.
Figure 4.2: Shown are two histogramms of voxelactivities: Left side with a
Kullback-Leibler divergence of 0.67 and on the right side with 0.12.
4.2 Simple Fit Method
Instead of fitting the activity values as smoothed by the particle filter (’particle
fit’), one can use another approach to calculate a voxel-wise decay map. One
can fit a mono-exponential function to the four activity values per voxel. In the
follwoing this method is called ’simple fit’.
For each method the Time Integrated Activity (TIA) in a specific source region
S was calculated by integrating, for every voxel, the fit function over time and
sum over all voxels.
TIAS = A0
∑
n∈S
∫ ∞
0
·e−
t
τeff,n dt
where S is the source region, n indicates one voxel, A0 denotes the injected
activity and τeff,n the half-life, which can differ between the voxels for both,
the ’simple fit’ and ’particle fit’ method. Note that the approximation an(t0) ≈
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A0∀ n ∈ S accounts for the fact that the complex metabolic processes which dis-
tribute the radioactive pharmaceutical in the body is generally unknown. Finally,
also the distribution of half-lives across all voxels in the VOIs was calculated.
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Chapter 5
Results
5.1 Parameter evaluation
Finding a good parameter configuration, which yields similar histograms of the
number of decays within an organ, and which also yields a good match to the
measured activity distribution of all activity values within a VOI, the standard de-
viations for the state evolution model and the observation model were considered
adjustable parameters. The configurations were computed for all 26 patients, and
for each configuration, the histogram of the number of decays per voxel was deter-
mined and compared with the averaged activity histogram. The KL was computed
for all configurations. The σobs was varied between 0.35 ≤ σobs ≤ 0.99. The con-
sidered standard deviations are rather large because the estimated precision of the
activity measurement through SPECT imaging is in this range according to [19].
In the following table, the KLs, averaged over all patients, are collected:
Table 5.1: Kullback - Leibler divergences, averaged over the entire patient cohort
model observation 0.35 0.5 0.75 0.99
0.01 0.12 0.17 0.17 0.17
0.10 0.16 0.17 0.17 0.17
0.25 0.16 0.16 0.16 0.16
0.35 0.58 0.54 0.48 0.46
The values in each row are very similar to each other, indicating that the KL
is rather robust against uncertanties in the observation model. The smallest value
for the KL is marked in blue.
As a second decision criterion for an optimal parameter configuration, the
relative deviation of the total number of decays estimated either by integrating the
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Table 5.2: Relative deviations of the sum of voxelwise integrated activities from
the corresponding whole organ integrated activity in percent
model observation 0.35 0.5 0.75 0.99
0.01 −34.2% −32.6% −32.6% −32.6%
0.10 −35.8% −33.7% −33.4% −33.4%
0.25 −44.4% −40.3% −39.0% −38.5%
0.35 −64.4% −59.3% −56.3% −55.9%
time-dependent activity at every voxel and then summing over all voxels within
the VOI or by integrating the whole organ (here the kidney) activity over time was
calculated.
In the following table the resulting relative deviations are collected. The devi-
ations for the total number of decays are large because of a high statistical uncer-
tainty in the voxel activity values. To correct for these large deviations, the voxel-
wise integrated activity map can be normalized with the total number of decays per
organ. For the following results, we choose the parameters as σobservation = 0.35
and σmodel = 0.10.
To obtain stable results for the single activity values, the number of particles
for each time step was varied. In figure 5.1 the determined difference between the
total number of decays per organ for different numbers of particles and the total
number of decays for 2000 particles is illustrated. With only 150 particles, the
difference to the reference value almost disappears.
Moreover, while applying the particle filter, different resampling schemes were
evaluated, but there was no difference in the total number of decays per organ.
Therefore we decided to perform no resampling. The possibility to loose too
much diversity is very low with only four time steps.
5.2 Voxelwise TAC
For each voxel, a state evolution model was defined through four measured time
points. According to the state evolution model and the observation model, par-
ticles were generated and an estimation of the true activity value was obtained
through its likelihood. An analytic function was then adapted to either the four es-
timates of the true activity values or the observed activity values. In figure 5.2, the
actual measurements and the estimates of the state evolution model as represented
by properly adapted analytic functions, whereby the adaptation to the observed
values is drawn in black and the adaptation to the estimates of the true activity
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Figure 5.1: Variation of the number of particles.
values is colored in grey. Through particle filtering, the outlier at the second time
point could be eliminated very well.
Figure 5.2: Time activity curves for two different voxels at four time steps.
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5.3 Whole patient
In figure 2.2, one slice of the SPECT images at four time points for one patient
have been illustrated. Now the voxelwise results for the integration of the TACs
are shown in figure 5.3. The red voxels in the right image, showing the results
from the simple fit method, are those with a diverging integral, the calculated
number of decays is equal to infinity.
Figure 5.3: One slice of the results for the particle filtering method (left) and the
simple fit method (right).
The voxelwise integration of the particle filtered activity values was performed
for the whole patient. For the segmented organs (kidney, spleen and tumor), a
corresponding half-life was calculated and used for the state evolution model. For
the voxels outside the VOIs, an over all voxels from the same tissue class averaged
half-life was calculated and used for the model. For each VOI, a histogram of the
number of decays per voxel was obtained and is shown in figure 5.4. A second
histogram is also shown, were the number of decays per voxel is presented, which
is calculated by a simple voxel-by-voxel integration. Both histograms are almost
indistinguishable.
Considering the histograms of all voxel-specific half-lives, which were used
in the analytic function for the determination of the TIA, the particle filter method
yielded histograms centered at the half-life from the state evolution model, while
the simple fit method very often yielded half-lives larger than the physical half-
life of Lutetium (see figure 5.5). Also the widths of the two distributions differ
considerably. The much narrower width of the distribution for the particle filter
method depends on the σ parameters of the SEM and the OM.
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Figure 5.4: Histograms of number of decays per voxel for the particle filter method
(blue) and the voxelwise simple fit of the four activity values (red).
Figure 5.5: Histograms of halflives per voxel for the particle filter method (blue)
and the voxelwise simple fit of the four activity values (red). The halflife for the
whole organ is 81.6h.
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Chapter 6
Discussion
In this work, we proposed a method for processing voxel-wise TACs prior to fitting
them to mono-exponentials and subsequently integrating them temporally. The
TACs were obtained by sequential, quantitative SPECT/CT imaging for dosimetry
of 26 patients under Lu-177 targeted radiotherapy. The proposed pre-processing
method is a Particle Filter, which belongs to the class of sequential Monte-Carlo
methods. The aim of the method is a de-noising of the observed TACs. The goals
were the following:
• The whole-organ TIA map, as obtained on basis of the filtered data, should
be as similar as possible to the conventional evaluation. The latter obtains
TIA maps by fitting and integrating the organ-averaged time-activity curve.
• The histograms of the TIA maps, resulting from the PF, should resemble the
TIA-histograms, as initially estimated from SPECT images.
We have shown that Particle Filters are suitable for a reduction in the variance
of the effective half-lives of voxels in kidneys, spleen, and tumors. Most notably,
the number of voxels which exhibit half-lives longer than the physical half-life of
the radioisotope is significantly reduced.
For two voxel-specific methods to estimate whole organ TIAs, namely par-
ticle fit (PFF) and simple fit (SF), we quantified deviations to whole-organ TIAs
estimated by time-integration of the whole organ activity.
When comparing the resulting half-lives, we found that application of particle
filtering results in a strong reduction of variance, compared to SF. As intended,
the voxel-specific half-lives for PFF were distributed around the half-life used
in the state evolution model. Importantly, the number of voxels which exhibit a
longer-than-physical half-life was greatly reduced with PFF, compared to SF. In
summary, the PFF method does not fix the half-life to a single value, rather it
exhibits a narrow distribution and reduces the number of implausible half-lives to
almost zero in our study.
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Unfortunately, literature for comparing different methods for fitting voxel-
specific TACs is scarce so far. Thus, no generally accepted standard-method ex-
ists. Guidelines recommend either not modelling at all, rather performing trape-
zoidal integration of TACs, or modelling by exponential functions [28, 26], al-
though these recommendations are usually in the context of whole-organ dosime-
try.
In the literature of voxel-based dosimetry in targeted radiotherapy, most groups
applied no modelling at all for the time period covered by imaging, and mono-
exponential extrapolation after the last imaging [25, 18, 30, 6, 23]. Jackson et
al. [10] used tri-exponential modelling of the TAC, but applied regularization in
order to limit the number of voxels with implausible TIA. In the study of Kost
et al. [14], the user could choose between mono- or bi-exponential modelling of
pharmacokinetics. However, the focus of their study was not on the comparison
of the different models and consequently they did not report on this.
Marcatili et al. [16] implemented an algorithm which automatically selects the
best model for each voxel, either pure mono-exponential decay or linear uptake
followed by mono-exponential decay, and no modelling and trapezoidal integra-
tion as fall-back if modelling fails. They did not provide a systematic comparison
between the different models but stated that the fall-back was used in less than
5% of voxels for their application (I-124 Positron-Emission Tomography (PET)).
However, it could be hypothesized that for SPECT imaging of typical Lu-177
activities, the image noise would be comparably higher than for PET, which po-
tentially could affect fitting of per-voxel TACs negatively.
To the best of our knowledge, the study of Sarrut et al. [24] is the only study
that systematically compared different models for voxel-wise TAC fitting. They
focused on an algorithm called VoMM, that automatically selected the best model
for fitting the TAC of individual voxels. The models considered were mono- or
bi-exponential functions with variable degrees-of-freedom of the fit ranging from
2 to 4 parameters. They compared the results obtained by VoMM and by using
fixed models for all voxels in a numerical experiment with varying noise levels
and also in one dosimetry patient. In any case, 6 imaging time points were used.
For the numerical experiment, they evaluated the Root Mean Squared Error be-
tween ground-truth and modelled TIAs and also the percentage of voxels which
could not be fit successfully (%FF). They found that the Root Mean Squared Error
and %FF was lower for VoMM as compared to the fixed models. Notably, they
also showed that a low count number and thus high noise level in a voxel’s TAC
would result in an increased Root Mean Squared Error and %FF. For their patient
data, they found that %FF was lower for the VoMM than for most fixed models.
However, one fixed model did have an even lower %FF.
Altogether, literature on this topic shows that voxel-wise fitting of TACs, sub-
sequent calculation of TIAs, and thus voxel-specific dosimetry is feasible. How-
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ever, it also turns out that especially the TAC fitting is most likely negatively
affected by noise. Most groups apply some technique to either circumvent mod-
elling of especially the early part of the TACs by using numerical integration or
implement some kind of regularization in order to limit the bias introduced by
voxel noise. Most groups did only assess if voxel-wise fitting could be done suc-
cessfully from an algorithmic point of view, but did not evaluate if a successful fit
resulted in feasible TIAs. Based on our experience and from our results obtained
by the simple fit method, we suspect that many voxels’ TIAs, although obtained
by successful fitting, are still incorrect. This problem could be alleviated by ap-
plication of Particle Filters, which could be understood as de-noising based on
a plausible assumption/model. Altogether, we think that particle filters offer an
interesting alternative to methods reported from literature and should be further
evaluated in forthcoming studies.
6.1 Conclusion
In this study, the challenge was to calculate the number of decays per voxel from
the SPECT-images. Therefore, a statistical method called particle filter was used.
With this method the voxelwise noise of the SPECT images could be removed by
matching the measuremenst to a physical model of the radioactive decay. This
method yields a homogeneous distribution of the decays per voxel by taking into
account different organs. The particle filter method was compared to a simple
fit method. The latter generally resulted in inhomogeneous decay maps where
certain voxels contained diverging numbers of decays. For 26 patients suffering
from a prostate cancer or a neuroendocrine tumor, the corresponding decay maps
could be determined reliably.
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